Psyence Biomedical Ltd (PBM)

NASDAQ

$3.20

$-0.25

(-7.12%)

Pre-Market

Psyence Biomedical Ltd (PBM) Live Price Chart

Last updated: ⁦2026-11-05 09:18:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Psyence Biomedical Ltd (PBM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.20, with a market capitalization of $12.55M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.92 to $18.62. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12.55M
Open	$3.44
Day's High	$57,533.44
Day's Low	$1.92
Previous Close	$3.29
Volume	16.85K
Average Volume	78.65K
P/E Ratio	--
52-Week High	$18.62
52-Week Low	$1.92
Dividend Yield	--
Earnings Date	--

Psyence Biomedical Ltd (PBM) Pre-Market Stock Price

Psyence Biomedical Ltd (PBM) is trading at $3.28 in pre-market trading as of 2026-11-05 00:31:00, down 0.33% ($0.01) from the previous close of $3.29

Pre-market trading shows how investors are pricing PBM before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Psyence Biomedical Ltd (PBM) 7-Day Stock Price Change

Over the past seven days, Psyence Biomedical Ltd (PBM) moved from $3.01 to $3.20, representing a gain of 6.15% ($0.19).

The stock traded between $2.70 and $3.98 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 82.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

PBM 52-Week Price Position

Position in Range: 7.6%

52W Low$1.92

52W High$18.62

PBM is currently trading at $3.20, placing it 7.6% of the way from its 52-week low of $1.92 to its 52-week high of $18.62. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Psyence Biomedical Ltd (PBM)?

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical Ltd Information

Employees	12
Exchange	NASDAQ
Company Website	https://www.psyence.com

How to Buy Psyence Biomedical Ltd (PBM) Stock on MEXC

Eligible investors can buy real shares of Psyence Biomedical Ltd (PBM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PBM and Place Your Order

Open the RealStocks trading page and search for PBM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Psyence Biomedical Ltd (PBM) stock price today?

Psyence Biomedical Ltd (PBM) is currently trading at $ 3.20, down 2.89% ($0.10) from the previous close of $ 3.29. Intraday prices update in real time during regular trading hours.

2.Is PBM stock going up or down today?

As of 2026-11-05 00:31:00, PBM is trading at $ 3.20, down 2.89% ($0.10) from its previous close of $ 3.29. The stock has traded between $ 1.92 and $ 57,533.44 during today’s regular session. Past price movements do not guarantee future results.

3.What is PBM pre-market price?

As of 2026-11-05 00:31:00, PBM is trading at $ 3.28 in pre-market trading, down 0.33% ($0.01) from the previous close of $ 3.29. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PBM after-hours price?

As of 2026-11-05 00:31:00, PBM is trading at $ 3.20 in after-hours trading, down 2.89% ($0.10) from the regular-session close of $ 3.29. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PBM stock trading now?

PBM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PBM sit relative to its 52-week high and low?

Over the past 52 weeks, PBM has traded between a low of $ 1.92 and a high of $ 18.62. At $ 3.20, the stock is positioned 7.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Psyence Biomedical Ltd in?

Psyence Biomedical Ltd (PBM) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Psyence Biomedical Ltd's market capitalization and where is it listed?

Psyence Biomedical Ltd is listed on the NASDAQ exchange with a market capitalization of $ 12.55M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PBM valued in terms of P/E ratio and EPS?

PBM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Psyence Biomedical Ltd pay a dividend?

Psyence Biomedical Ltd pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.